This theme does not sound to me in the forum, I copy you a news that came out a few months ago in Channel Diabetes and that I have been able to know this march at a good pace, what do we do buy insuchock or do we wait for the Novo Nordisk?
There has been a lot lately in Insuclock, a device for the control of the insulin supplied.The price of it is about € 249.00, abusive?because as always depends on what each one can spend and what we want to have for the quality of our diabetes, but of course everything has an extra cost and a surprise that is not located at least easily on their website when buying,Thanks to Sacarino I have been able to find out about the second part of Insuclock that I have only heard to talk to him and it is the plan you want to use to be able to take out all the benefit to the Insumer.As if we had a mobile phone because we have the free fee (free) or already those of payment that are really worth it, according to us indicates with the free you cannot or get reports in addition to being swallowing us advertising (logical if it is free) And it is quite scarce, that is, we have to go to another upper version.Do you know anything about it?It doesn't matter if they give it to you the first year because then you have to keep paying and cheap little.I carry a bomb and it is not valid but if I had to get one because I am not sure what I would do, not because of the initial cost but for the extra cost of the added plan because I would choose the expensive in case of choosing any.
Novo Nordisk announced the launch of its two insulin feathers connected earlier this month.The company has just confirmed in recent days that it plans to launch the devices, known as the Novopen 6 and Novopen Eco Plus, worldwide, in early 2019.
"People who need insulin are not yet achieving adequate glycemic control," according to Anders Dyhr Toft, corporate vice president of commercial innovation in Novo Nordisk, in statements to the technology and health information portal, Mobihealthnews, where we have found this information.
“Sometimes people with diabetes skip some injection.They almost always fail to apply the specific dose.These are the areas in which we believe that digital health solutions, such as connected insulin feathers, can allow the patient to get better control.And the first step we are taking to help the patient to obtain better control is through the connection of our insulin feathers connected to smartphones, and in doing so, the connected insulin feathers will send data to the phone and integration withDiabetes management platforms. ”
In addition to announcing connected insulin feathers, the Danish pharmaceutical company announced that it will also be technologically associated with Dexcom, Glooko and Roche to allow their applications to be used with the new connected insulin feathers.The agreement with Roche we advanced it a few days ago on the occasion of the EASD Congress, you can see here the complete information Link Novo Nordisk also has an existing relationship withIBM Watson Health.
Connected insulin feathers will allow patients to track trends in insulin use and discuss them with your doctor.Over time, connectivity opens the door to endless possibilities for technology to help patients in their adhesion to treatment.
What we do not know is still the exact date on which these new devices may be requested or acquired in Spain.The company's commitment is during 2019. We will remain attentive to these novelties. Link
Technology continues to progress but why don't they do the smallest pen?since its creation .We have to carry so many things that I think we are always looking for the products that we carry in the backpack are smaller, of course that economically has the entry of the feathers to spend money on a lower size product?:(